Navigating Late Line R/R Multiple Myeloma: Treatment Landscape, Patient Care, and Quality of Life - Episode 7
Practical Considerations for Therapies Considered by the Patient and Caregivers in RRMM
Panelists discuss how patients and caregivers considering late-line multiple myeloma therapies must navigate practical considerations including lengthy hospital stays for CAR-T cell therapy (typically two to four weeks), insurance approval challenges, travel to specialized treatment centers, the potential need for caregivers to take extended leave from work, management of posttreatment monitoring requirements, eligibility criteria related to organ function and performance status and planning for potential complications such as cytokine release syndrome or neurological toxicities that might require urgent care access.
Video content above is prompted by the following:
- What practical considerations should patients and caregivers be aware of when considering these therapies (e.g., hospital stays, eligibility, timing)?
Related Content:
